Status:
COMPLETED
Study of the Immune Response After Vaccination in Multiple Myeloma Patients
Lead Sponsor:
Wake Forest University Health Sciences
Collaborating Sponsors:
Vince Lombardi Cancer Clinic
Conditions:
Multiple Myeloma
Myeloma, Multiple
Eligibility:
All Genders
50+ years
Brief Summary
This study will collect blood samples from healthy volunteers and volunteers with multiple myeloma who are going to get the seasonal flu, pneumonia, haemophilus influenzae B (HIB), and/or meningococcu...
Detailed Description
This study will consist of a prospective blood sample collection to gather baseline data to confirm antibody protection from vaccines in the Aurora Health Care multiple myeloma (MM) patients. The ove...
Eligibility Criteria
Inclusion
- 50 years old or over
- planning on getting the seasonal flu and/or pneumonia vaccine as part of normal care
- have multiple myeloma, or don't have multiple myeloma and want to serve as a health control
Exclusion
- \- do not meet inclusion criteria
Key Trial Info
Start Date :
December 30 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 10 2017
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT02294487
Start Date
December 30 2014
End Date
August 10 2017
Last Update
October 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aurora Health Care
Milwaukee, Wisconsin, United States, 43233